Medicine to maintain weight loss after weight-loss shots
Part of Hormones & metabolism clinical trials.
This study tests a new medicine called ALV-100 to see if it can help people who have already lost weight with a weight-loss injection or pill keep the weight off. You must be currently on a stable weight-loss medicine and have lost at least 10% of your body weight to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your BMI is 27 or higher (BMI is a measure of body size based on height and weight).
- You have been taking a weight-loss medicine (like Ozempic or Wegovy) at the same dose for at least 3 months.
- You have lost at least 10% of your body weight while on this medicine, and your weight has stayed stable for the last 3 months.
- You are willing to keep your current diet and exercise routine during the study.
- You do not have type 1 or type 2 diabetes, and you have not had weight-loss surgery or a weight-loss device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental injection called UBT37034 to see if it is safe and how the body handles it. It is for people who are overweight but otherwise healthy. By joining, you could help find new ways to help with weight control—and you'll receive close monitoring and care.
This study tests a new investigational injection called MWN110 in people who are overweight or have obesity. The goal is to see if the drug is safe and how it affects the body, which may help with weight management.
This trial tests an investigational injection called MWN109 to help adults with overweight or obesity lose weight. It is a phase 3 study, meaning it is being tested in a large group of people to see how well it works and if it is safe.
This trial tests a new medication called ALV-100 for safety and how well it works in people who are overweight or have type 2 diabetes. It might help if you have a higher body weight and want to try a new treatment option.
This study tests a new medicine to help adults with obesity or overweight lose weight. It's for people who have had trouble losing weight in the past and don't have diabetes.
This study tests a new injection (MWN117) in healthy people and in people with obesity. It aims to see if the drug is safe and how the body handles it, which may eventually help with weight management.
Hear when a new Overweight , Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.